ESR1 and neoplasm: The positive feedback loop between ERα and LINC02568 suggested that combination therapy with ASO targeting LINC02568 and endocrine therapy drugs, such as tamoxifen and fulvestrant (ICI), might achieve synergistic effects on tumor inhibition.